Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06771817 · ClinicalTrials.gov registry record · NA
Empowering Perinatal Adolescents Through Writing
A NA study of PTSD - Post Traumatic Stress Disorder and PTSD and Trauma-related Symptoms, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06771817: Recruiting NA study of PTSD - Post Traumatic Stress Disorder and PTSD and Trauma-related Symptoms, sponsored by University of Texas Southwestern Medical Center.
NCT06771817 is a NA study of PTSD - Post Traumatic Stress Disorder and PTSD and Trauma-related Symptoms that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 30 participants, below the 278-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06771817, a NA study of PTSD - Post Traumatic Stress Disorder and PTSD and Trauma-related Symptoms, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a feasibility and acceptability study of Written Exposure Therapy (WET) for PTSD in pregnant and postpartum adolescents and youth with PTSD.
Primary Outcome
Feasibility will be assessed based on recruitment, retention and treatment adherence rates. Acceptability will be evaluated through participant feedback, including satisfaction with the intervention and willingness to engage in treatment. The primary outcome will be the percentage of participants who complete treatment within 4 weeks, for a 12-week study period. We expect at least 70% of participants will be able to complete treatment within 4 weeks.
Conditions Studied
Interventions
- BEHAVIORAL Written Exposure Therapy
Study Locations (1)
Texas
- UT Southwestern Center for Depression Research and Clinical Care - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-26 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT06771817 shows while recruiting
NCT06771817 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 278-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (89% lower).
The record links to 4 conditions, with PTSD - Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Written Exposure Therapy is the first listed.
NCT06771817 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06771817 about?
NCT06771817 is a clinical study titled "Empowering Perinatal Adolescents Through Writing". This is a feasibility and acceptability study of Written Exposure Therapy (WET) for PTSD in pregnant and postpartum adolescents and youth with PTSD.
What is the current status of trial NCT06771817?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-26. Estimated completion is 2026-08-31.
What conditions does trial NCT06771817 study?
This clinical trial studies the following conditions: PTSD - Post Traumatic Stress Disorder, PTSD and Trauma-related Symptoms, Post-Traumatic Stress Disorder in Adolescence, Pregnancy and PTSD.
What interventions are being tested in trial NCT06771817?
The interventions under investigation include: Written Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06771817?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06771817 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD - Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06771817's enrollment target sits among peer trials
30 12th of 14 higher than 3 of 14 other PTSD - Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD - Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Diet and Microbiome Interactions: Application in Posttraumatic Stress Disorder in Adults Consuming Vegetable Drinks
RECRUITING · NA
-
Transcranial Magnetic Stimulation in Veterans With PTSD
RECRUITING · NA
-
Restorative Early Sleep Treatment After the Emergency Department
RECRUITING · NA
-
Evaluating Evidenced Based Options for PTSD Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI